- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06624124
SimuVersity Medical Center: Pain and Opioid Management Training in Diverse Patient Populations
Study Overview
Status
Conditions
Detailed Description
Management of chronic pain and opioid use/misuse is challenging for clinicians and students, especially when working with diverse and underserved patient populations, and very few low-cost, flexible, highly-engaging, and effective learning resources are available to help the healthcare workforce best learn to manage these unique health concerns. Gamification holds promise as a user-friendly, fun, engaging and effective teaching strategy, especially for healthcare applications. SimuVersity Medical Center is an immersive 3D gaming platform that will engage students and practicing clinicians in a unique and captivating learning experience focused on pain and opioid management in diverse patient groups.
SimuVersity Medical Center is an innovative platform solution to education and training in specialty topics in healthcare. This novel learning platform will permit learners to explore a 3D virtual hospital space and can interact with objects, virtual colleagues/trainers and virtual patients (imbued with artificial intelligence) to learn and practice new clinical skills. The platform is built for ease-of-use with simple character controls that non-game-savvy learners find intuitive and easy. The graphical interface is clean and clear and the software runs on all modern computing platforms. The control intervention consists of traditional powerpoint slide-based training and text-base case studies for review.
This study aims to compare the effectiveness of the new educational activity/game (a novel, engaging digital-training plus interaction with virtual patients to practice skills) in meeting clinical learning objectives and outcomes compared to traditional didactic (powerpoint slide-based training and text-base case scenarios) approaches to provider and student education and satisfaction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ages 18-80 years
- English-speaking
- Graduate-level health professional students and faculty at the Medical University of South Carolina
- Willingness to volunteer to play the new educational game and complete questionnaires regarding satisfaction, knowledge acquisition, value, ease of use and ability to meet learning objectives
Exclusion Criteria:
- Age outside the predefined range
- Not a student or faculty at MUSC
- Not willing or able to participate in the learning activity or complete study related questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training using AI-powered SimuVersity Training Platform
Students and faculty will receive training on diversity considerations in pain and opioid management via an online gamified platform with AI-powered virtual patients to apply knowledge.
|
Use of a video game-based training platform
|
|
Active Comparator: Training using traditional text-base methods
Students and faculty will receive training on diversity considerations in pain and opioid management via written materials and text-base case studies to apply knowledge.
|
Use of a traditional text-based training platform
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-Post Training Knowledge Test
Time Frame: From enrollment to the end of the training and assessment (2 hours later)
|
Multiple-choice knowledge test on diversity considerations in pain and opioid management
|
From enrollment to the end of the training and assessment (2 hours later)
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00137370
- 1R41DA059281-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on None Volunteer
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Hofstra UniversityOmniActive Health TechnologiesNot yet recruiting
-
University of OttawaAllerganActive, not recruiting
-
Arch Biopartners Inc.CompletedNone - Study is to Determine Safety in Healthy ParticipantsAustralia
-
Rippe Lifestyle InstituteCompletedConditions: None. Focus: Understanding the Obesogenic Potential of Fructose Containing SugarsUnited States
-
University of ValenciaUniversity Of Perugia; University of Eastern Finland; European Union; Universitat... and other collaboratorsActive, not recruitingNone - Study is to Determine Safety in Healthy ParticipantsSpain
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
Hospices Civils de LyonNot yet recruiting
-
AbbVieNot yet recruiting
-
TrueLab Biopharmaceutical Co., LtdSAPRO Consulting Pty LtdRecruiting
Clinical Trials on Gamified Training in Diversity Considerations in the Management of Pain and Opioid Use
-
Helena PiccininiNova Scotia Health AuthorityWithdrawnGestational Weight GainCanada
-
Vanderbilt UniversityCompletedGlaucomaUnited States
-
Central Hospital, Nancy, FranceNot yet recruitingExposure, RadiationFrance
-
FHI 360International Food Policy Research Institute; Project Concern International...Completed
-
Hospital Clinic of BarcelonaAmgen; University of BarcelonaRecruitingFracture of FemurSpain
-
Assistance Publique - Hôpitaux de ParisANRS, Emerging Infectious DiseasesNot yet recruitingPost-acute COVID-19 SyndromeFrance
-
Mustafa Kemal UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompletedLynch Syndrome | Hereditary Non-polyposis Colon Carcinoma | HNPCCBelgium
-
Karadeniz Technical UniversityCompletedSurgery | Appendicitis | ERASTurkey (Türkiye)
-
University Hospital, ToulouseRecruitingStroke | RéhabilitationFrance